Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)
Clinical trial NCT04107727 · COMPLETED
Trial details
- NCT number
- NCT04107727
- Sponsor
- PETHEMA Foundation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-05
- Primary completion
- 2024-10-03
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.